Live feed
Filing
SC 13D
SC 13D0001654954-19-014157·Gem Pharmaceuticals LLC
Schedule 13D ownership disclosure
MONOPAR THERAPEUTICS INC
Security class unavailable · CUSIP: 61023L108
Event date: 2019-12-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 29.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001654954-19-014157
- Form type
- SC 13D
- Filer
- Gem Pharmaceuticals LLC
- CIK
- CIK 1727356
- Filed
- Dec 23, 2019
- Reporting period
- Dec 18, 2019
- Description
- Schedule 13D beneficial ownership